MICHAEL ROBERTSON to Pain
This is a "connection" page, showing publications MICHAEL ROBERTSON has written about Pain.
Connection Strength
0.082
-
A ?-opioid receptor superagonist analgesic with minimal adverse effects. Nature. 2026 Apr; 652(8112):1393-1404.
Score: 0.049
-
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial. Lancet Haematol. 2020 Sep; 7(9):e660-e670.
Score: 0.033